GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (STU:37Z) » Definitions » Accumulated other comprehensive income (loss)

Allakos (STU:37Z) Accumulated other comprehensive income (loss) : €0.02 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Allakos Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Allakos's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €0.02 Mil.

Allakos's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€0.30 Mil) to Dec. 2024 (€0.13 Mil) and declined from Dec. 2024 (€0.13 Mil) to Mar. 2025 (€0.02 Mil).

Allakos's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-0.27 Mil) to Dec. 2023 (€0.05 Mil) and increased from Dec. 2023 (€0.05 Mil) to Dec. 2024 (€0.13 Mil).

Allakos Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Allakos's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allakos Accumulated other comprehensive income (loss) Chart

Allakos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only 0.01 -0.14 -0.27 0.05 0.13

Allakos Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.30 0.13 0.02

Allakos Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Allakos Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Allakos's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Allakos Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (STU:37Z) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
DYAI OKUR CVKD CASI KZR FBLG PYPD INKT AAGH CYCC VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
825 Industrial Road, Suite 500, San Carlos, CA, USA, 94070
Website
https://www.allakos.com
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

Allakos Headlines

No Headlines